Jiangsu Simcere Pharmaceutical

NCT06680921

Phase 3, Active, not recruiting, 2024, 482 people, 8 Nov 2024, clinicaltrials.gov

NCT05293964

Phase 1, Active, not recruiting, 2022, 214 people, 24 Mar 2022, clinicaltrials.gov

NCT04914598

Phase 3, Active, not recruiting, 2021, 290 people, 4 Jun 2021, clinicaltrials.gov

NCT04902885

Phase 3, Completed, 2021, 95 people, 26 May 2021, clinicaltrials.gov

NCT04440436

Collaborator, Phase 1/2, Recruiting, 2020, 52 people, 19 Jun 2020, clinicaltrials.gov

NCT02916420

Phase 3, Status unknown, 2016, 73 people, 27 Sept 2016, clinicaltrials.gov

NCT02722694

Phase 3, Status unknown, 2016, 360 people, 30 Mar 2016, clinicaltrials.gov

NCT02283476

Phase 3, Status unknown, 2014, 200 people, 5 Nov 2014, clinicaltrials.gov

NCT02275299

Phase 4, Status unknown, 2013, 240 people, 27 Oct 2014, clinicaltrials.gov

NCT02088515

Phase 4, Completed, 2013, 290 people, 17 Mar 2014, clinicaltrials.gov

NCT01909856

Phase 2, Completed, 2011, 92 people, 29 Jul 2013, clinicaltrials.gov

NCT01548001

Phase 4, Status unknown, 2012, 910 people, 8 Mar 2012, clinicaltrials.gov

NCT01531790

Phase 1, Completed, 2011, 19 people, 13 Feb 2012, clinicaltrials.gov

NCT01327235

Phase 2, Completed, 2011, 336 people, 1 Apr 2011, clinicaltrials.gov